JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264375

Anti-YTHDC1 antibody

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Polyclonal YTHDC1 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human YTHDC1 aa 50-100.

View Alternative Names

KIAA1966, YT521, YTHDC1, YTH domain-containing protein 1, Splicing factor YT521, YT521-B

2 Images
Immunoprecipitation - Anti-YTHDC1 antibody (AB264375)
  • IP

Supplier Data

Immunoprecipitation - Anti-YTHDC1 antibody (AB264375)

[Target] was immunoprecipitated from 6 μg of HEK-293T cells whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) with ab264375. Western blot was performed from the immunoprecipitate using ab264375 at 0.4 μg/ml.

Lane 1 : HEK-293T cell lysate 6 μg (Input).
Lane 2 : Rabbit anti-YTHDC1 antibody.
Lane 3 : Control IgG IP in HEK-293T cell lysate.

Chemiluminescence with an exposure time of 30 seconds.

Cells prepared using NETN lysis buffer.

All lanes:

Immunoprecipitation - Anti-YTHDC1 antibody (ab264375)

Predicted band size: 85 kDa

false

Western blot - Anti-YTHDC1 antibody (AB264375)
  • WB

Supplier Data

Western blot - Anti-YTHDC1 antibody (AB264375)

Lysates prepared in NETN lysis buffer.

All lanes:

Western blot - Anti-YTHDC1 antibody (ab264375) at 0.1 µg/mL

Lane 1:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 50 µg

Lane 2:

HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg

Lane 3:

Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 50 µg

Predicted band size: 85 kDa

true

Exposure time: 30s

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

Synthetic Peptide within Human YTHDC1 aa 50-100. The exact immunogen used to generate this antibody is proprietary information.

Q96MU7

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-10 µg/mg of lysate", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

YTHDC1 also known as YT521-B is a nuclear protein involved in mRNA processing. It belongs to the YTH domain family recognized for binding m6A-modified RNA. The protein has a mass of approximately 82 kDa. Expression of YTHDC1 occurs mainly in the nucleus but may also be found in other cellular compartments. Its widespread presence includes tissues such as the brain and liver suggesting its diverse functional roles.
Biological function summary

YTHDC1 operates in the regulation of mRNA splicing and transportation. It associates with spliceosome components to influence alternative splicing decisions. YTHDC1 part of the m6A reader complex recognizes the m6A methylation mark on RNA aiding in the control of mRNA fate. Additionally its interactions with certain proteins affect RNA stability and translation essential for proper gene expression regulation.

Pathways

YTHDC1 plays a significant role in RNA metabolism and the cellular response to stress. Involvement in the mRNA splicing pathway highlights its contribution to gene expression regulation. YTHDC1 interacts with proteins like SRSF3 and SRFS10 which modulate RNA splicing and stability. Another pathway includes its role in the cellular stress response where YTHDC1 helps maintain RNA integrity linking it to adaptive responses in cells.

YTHDC1 captures interest regarding cancer and neurodegenerative diseases. Abnormal expression levels or mutations in YTHDC1 have associations with various cancer types hinting at its role in tumorigenesis. Alterations in YTHDC1 expression impact splicing patterns and gene expression potentially influencing cancer progression. Additionally YTHDC1's connection to neurodegeneration involves proteins such as FUS and TDP-43 which are associated with disorders like amyotrophic lateral sclerosis (ALS) suggesting that YTHDC1 may play a role in RNA metabolism dysregulation observed in these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed : 25242552, PubMed : 26318451, PubMed : 26876937, PubMed : 28984244). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed : 25242552, PubMed : 26318451). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed : 26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed : 26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping : this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed : 26876937). May also regulate alternative splice site selection (PubMed : 20167602). Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3 : interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export (PubMed : 28984244). Involved in S-adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity). Also recognizes and binds m6A on other RNA molecules (PubMed : 27602518). Involved in random X inactivation mediated by Xist RNA : recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist (PubMed : 27602518). Also recognizes and binds m6A-containing single-stranded DNA (PubMed : 32663306). Involved in germline development : required for spermatogonial development in males and oocyte growth and maturation in females, probably via its role in alternative splicing (By similarity).
See full target information YTHDC1

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Cellular & molecular biology letters 30:109 PubMed41039223

2025

RSL3 promotes PARP1 apoptotic functions by distinct mechanisms during ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Dejian Chen,Fei Xie,Yimei Mo,Dan Qin,Binjiao Zheng,Lingyan Chen

Cell death discovery 11:417 PubMed40883266

2025

METTL3-mediated m6A modification of circCDKAL1 regulates macrophage M1 polarization and nasal epithelial cell barrier function in allergic rhinitis through IGF2BP2/JARID2/HMGB1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiabin Zhan,Dan Luo,Yunlong Fu,Yu Zhou,Rui Li,Xin Wei

International journal of biological sciences 20:2092-2110 PubMed38617538

2024

Colchicine Blocks Abdominal Aortic Aneurysm Development by Maintaining Vascular Smooth Muscle Cell Homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Min Chen,Dafeng Yang,Yangzhao Zhou,Chongzhe Yang,Wenhui Lin,Jie Li,Jitao Liu,Jiamin Ye,Wenhui Huang,Wentao Ma,Wei Li,Jiyan Chen,Ying Zhang,Guo-Ping Shi,Jianfang Luo,Jie Li,Songyuan Luo

Inflammation 47:469-482 PubMed37917328

2023

Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Tianping Bao,Xiangye Liu,Jian Hu,Mengmeng Ma,Jingyan Li,Linxia Cao,Bingrui Yu,Huaiping Cheng,Sai Zhao,Zhaofang Tian

International journal of biological sciences 19:4672-4688 PubMed37781028

2023

Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaogang Wang,Qianyu Chen,Ziqian Bing,Shizhen Zhou,Zhen Xu,Yayi Hou,Yue Zhao,Shuli Zhao,Tingting Wang

Cell proliferation 56:e13400 PubMed36642844

2023

Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi Chen,Weiqiang Ruan,Chunhao Guo,Ke Chen,Le Li,Jihua Tian,Zhiquan Hu,Dan Peng,Xing Zeng

FEBS open bio 13:195-208 PubMed36468944

2022

Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Hu,Feifei Lv,Na Li,Xuewei Yuan,Liru Zhang,Shuangling Zhao,Linyu Jin,Yongle Qiu

Discover. Oncology 13:89 PubMed36114893

2022

METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Guoying Zhang,Tianjun Wang,Zihui Huang,Yuanyuan Chen,Li Sun,Xia Xia,Fang He,Chenying Fan,Shukui Wang,Wanli Liu

Retrovirology 19:4 PubMed35101069

2022

YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah N'Da Konan,Emmanuel Ségéral,Fabienne Bejjani,Maryam Bendoumou,Mélissa Ait Said,Sarah Gallois-Montbrun,Stéphane Emiliani

Autophagy 18:1318-1337 PubMed34657574

2021

mA reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin.

Applications

Unspecified application

Species

Unspecified reactive species

Diefei Liang,Wei-Jye Lin,Meng Ren,Junxiong Qiu,Chuan Yang,Xiaoyi Wang,Na Li,Tingting Zeng,Kan Sun,Lili You,Li Yan,Wei Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com